General Information of the Compound
| Compound ID |
CP0502089
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[1-[2-[1-[5-(tert-butylsulfamoyl)-2-chloro-4-fluorobenzoyl]-4-(3-fluorophenyl)piperidin-4-yl]ethyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)-N-prop-2-enylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H51ClF2N4O6S2
|
||||||||||||||||||
| Molecular Weight |
833.464
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(CC3)N(CC=C)C(=O)Cc3ccc(cc3)S(C)(=O)=O)(CC2)c2cccc(F)c2)c(Cl)cc1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H51ClF2N4O6S2/c1-6-19-48(38(49)25-29-10-12-33(13-11-29)55(5,51)52)32-14-20-46(21-15-32)22-16-41(30-8-7-9-31(43)26-30)17-23-47(24-18-41)39(50)34-27-37(36(44)28-35(34)42)56(53,54)45-40(2,3)4/h6-13,26-28,32,45H,1,14-25H2,2-5H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
WNMZFHHBLYXUSV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound